Archive for December, 2005
« Previous Entries Next Entries »FDA Strengthens Warning For Pregnant Women Using Paxil After Two Studies Link Use To Fetal Heart Defects
Thursday, December 29th, 2005FDA on Thursday issued a public health advisory warning pregnant women and physicians about an increased risk of fetal heart defects from taking GlaxoSmithKline’s antidepressant Paxil — known generically as paroxetine — during the first three months of pregnancy, the … click link for more info.
Aetna To Increase Payments to Physicians Participating in Depression Management Program, USA
Thursday, December 29th, 2005Aetna CEO John Rowe on Wednesday is expected to announce a plan under which the insurer will increase payments to physicians who participate in a depression management program focusing on screening and follow-up consultations, the New York Times reports… click link for more info.
NICE guidance sets new standards for treating depression in children and young people, UK
Thursday, December 29th, 2005The National Institute for Health and Clinical Excellence (NICE) and the National Collaborating Centre for Mental Health have today (28 September) launched a clinical guideline on the treatment and management of depression in children and young people. The guideline recommends that - - Children and young people with moderate to severe depression should be offered, as a first-line treatment, a specific psychological therapy (such as cognitive behavioural therapy, interpersonal therapy or family therapy of at least 3 months’ duration)… click link for more info.
Wyeth Submits New Drug Application For Desvenlafaxine Extended Release (DVS-233) For Depression
Wednesday, December 28th, 2005Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), announced that it has submitted a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for desvenlafaxine extended release (DVS-233) for the treatment of major depressive disorder (MDD). Desvenlafaxine extended release represents Wyeth’s ongoing commitment to research and development of new antidepressant therapies… click link for more info.
SSRIs Boost Brain Growth, Hopkins Scientists Report
Sunday, December 25th, 2005The beneficial effects of a widely used class of antidepressants might be the result of increased nerve-fiber growth in key parts of the brain, according to a Johns Hopkins study being published in the January 2006 issue of the Journal of Neurochemistry. The study on rats, led by Vassilis E… click link for more info.
FDA Strengthens Warning For Pregnant Women Using Paxil After Two Studies Link Use To Fetal Heart Defects
Saturday, December 24th, 2005FDA on Thursday issued a public health advisory warning pregnant women and physicians about an increased risk of fetal heart defects from taking GlaxoSmithKline’s antidepressant Paxil -- known generically as paroxetine -- during the first three months of pregnancy, the … click link for more info.
FDA Strengthens Warning For Pregnant Women Using Paxil After Two Studies Link Use To Fetal Heart Defects
Saturday, December 24th, 2005FDA on Thursday issued a public health advisory warning pregnant women and physicians about an increased risk of fetal heart defects from taking GlaxoSmithKline’s antidepressant Paxil -- known generically as paroxetine -- during the first three months of pregnancy, the … click link for more info.
Combating Depression In Women With Nursing Interventions
Friday, December 23rd, 2005Low-income women at risk of depression can be helped through the use of cognitive-behavioral interventions including affirmation and thought stopping, recent research shows. In a study lead by Ann R. Peden at the University of Kentucky and funded by the National Institute of Nursing Research and the National Institutes of Health, a group of low-income single mothers received a 6-week group intervention that assisted them in changing their thinking style… click link for more info.
One Third Of Patients Hospitalized For Depression Also Has A Substance Abuse-related Mental Disorder, USA
Friday, December 23rd, 2005One third of the 713,000 Americans hospitalized for depression or other affective disorders in 2003 also had a secondary diagnosis of substance abuse, such as alcohol or cocaine, according to the federal Agency for Healthcare Research and Quality. More than half of hospital admissions for depression began in the emergency room… click link for more info.
New Book "Coping With Depression: From Catch-22 To Hope", By Renowned Psychologist Offers Hope To Depressed Patients And Their Doctors
Friday, December 23rd, 2005"Coping With Depression: From Catch-22 to Hope", a new book on the symptoms and treatment of depression, is now available through the American Psychiatric Publishing Inc. (APPI), the world’s premier publisher of books, journals, and multi-media on psychiatry. This important new release offers new and innovative perspectives to help mental health professionals and patients better understand and treat depression… click link for more info.
« Previous Entries Next Entries »